The nurse is caring for a client receiving ciprofloxacin (Cipro) for the treatment of a urinary tract infection (UTI). The nurse will include which black box warning (BBW) in the discharge education?
This medication can cause endometrial cancers.
This drug has a black box warning for causing tendon rupture.
This medication can cause thromboembolic events.
This medication can cause thrombocytopenia.
The Correct Answer is B
A. There is no established link between ciprofloxacin and endometrial cancers; this warning does not apply.
B. Ciprofloxacin has a black box warning for the risk of tendon rupture and tendinopathy, particularly in older adults and those concurrently taking corticosteroids.
C. Thromboembolic events are not specifically associated with ciprofloxacin; thus, this warning is not applicable.
D. Thrombocytopenia is a potential side effect of various medications but is not the primary concern associated with ciprofloxacin use.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is B
Explanation
A. Topical ointment has a slower onset as it must be absorbed through the skin before it can exert its effects.
B. Sublingual nitroglycerin provides rapid relief of angina symptoms because it is absorbed quickly into the bloodstream through the mucous membranes in the mouth, allowing for an immediate effect.
C. Transdermal patches release nitroglycerin slowly over time, leading to a delayed onset of action.
D. Sustained-release formulations are designed for prolonged effects rather than rapid onset, making them slower to take effect compared to sublingual administration.
Correct Answer is B
Explanation
A. Daily weight monitoring is not specifically indicated for doxazosin, and significant weight loss is typically not a primary concern with this medication.
B. Doxazosin can cause first-dose hypotension, leading to dizziness; thus, the client should be advised to lie down after the initial dose to minimize this risk.
C. Increasing potassium intake is not necessary with doxazosin; there are no direct interactions that would warrant dietary changes regarding potassium.
D. Impaired taste is not a commonly reported side effect of doxazosin; this statement is misleading and not relevant to the medication's profile.